Concepedia

Adonia E. Papathanassiu

AE

8

Publications

660

Citations

8

H-Index

1999

Active since

Affiliations

Aegerion Pharmaceuticals (United States)(Current)

CASI Pharmaceuticals (United States)

Imperial College London

Adonia E. Papathanassiu is an author at Aegerion Pharmaceuticals (United States) specializing in medicine, pharmacology, and tumor biology.

Top concepts

Publications per year

1999–2020

8

Publications

8

BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases

Adonia E. Papathanassiu, Jeong‐Hun Ko, Martha Imprialou et al. · Nature Communications · 2017 · 228 citations · Full text

Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.

Todd Hembrough, Glenn M. Swartz, Adonia E. Papathanassiu et al. · PubMed · 2003 · 197 citations

, , +19

Tissue Factor Pathway Inhibitor Inhibits Endothelial Cell Proliferation via Association with the Very Low Density Lipoprotein Receptor

Todd Hembrough, José F. Ruiz, Adonia E. Papathanassiu et al. · Journal of Biological Chemistry · 2001 · 75 citations · Full text

BCAT1 affects mitochondrial metabolism independently of leucine transamination in activated human macrophages

Jeong‐Hun Ko, Antoni Olona, Adonia E. Papathanassiu et al. · Journal of Cell Science · 2020 · 43 citations · Full text

, , +27

cAMP and cGMP in Human Parotid Saliva: Relationships to Taste and Smell Dysfunction, Gender, and Age

Robert I. Henkin, Irina Velicu, Adonia E. Papathanassiu · The American Journal of the Medical Sciences · 2007 · 36 citations

, , +6

Rows per page

1–5 of 8